NCT03980665View on ClinicalTrials.gov

The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions
HIV/AIDS
Interventions
DRUG

Arsenic Trioxide

a arsenic class of mineral, clinically approved for treating acute promyelocytic leukemia

Trial Locations (1)

510060

RECRUITING

Guangzhou 8th People's Hospital, Guangzhou

All Listed Sponsors
collaborator

Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences

UNKNOWN

lead

Guangzhou 8th People's Hospital

OTHER